CORRIGENDUM FOR 10.1210/jc.2011-3213
In the article “Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline” by Berglund L, et al (J Clin Endocrinol Metab. 2012;97(9):2969–2989; doi: 10.1210/jc.2011-3213) the authors wish to clarify terminology within the published paper: Language related to “Over-the-counter Omega-3” should more accurately refer to “non-prescription preparations” to reflect that there is currently no Over-the-counter Omega-3 option. It is available as a dietary supplement or a prescription. The authors regret any confusion that may have resulted from the published term.